The 595‐nm Wavelength Pulsed Dye Laser for Pediatric Port‐Wine Birthmarks and Infantile Hemangiomas: A Systematic Review
Lasers in Surgery and Medicine · 2025-01 · 57 (1) · 27-36
DOI: 10.1002/lsm.23864 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 16.12.2024. Verfasst von David A Hashemi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Laser & Skin Surgery Center of New York, New York, New York, USA. Hauptthemen laut MEDLINE: Lasers, Dye, Port-Wine Stain, Hemangioma, Skin Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Introduction
The 595‐nm wavelength pulsed dye laser (PDL) is well‐established in the treatment of vascular lesions. In June 2023, it received FDA clearance for the treatment of port‐wine birthmarks (PWB) and infantile hemangiomas (IH) in the pediatric population.
Objective
Review the evidence regarding the efficacy, safety, and implications of using PDL for management of pediatric PWB and IH.
Methods
A systematic literature search was performed to identify peer‐reviewed articles and clinical trials published between July 2002 and December 2022 in which PDL was used to treat pediatric PWB and IH.
Results
After application of criteria, 33 journal articles with 7725 total patients were included. Only 16 (0.8%) of the 2,033 patients with PWB and 11 (0.2%) of the 5692 patients with hemangioma reported permanent adverse effects including scarring, keloids, or permanent pigmentation change, and none reported blindness or other serious injury. Good, excellent, or complete clearance after PDL–on average or in greater than 50% of patients–was reported in 17 of 19 studies (89%) that reported these measures for PWB, and seven of the seven studies (100%) for IH.
Conclusion
The 595‐nm PDL is an excellent treatment option for early intervention in pediatric patients with PWB or IH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Laser & Skin Surgery Center of New York, New York, New York, USA.
- Department of Dermatology, Laser & Skin Surgery Center of Pennsylvania, Devon, Pennsylvania, USA.
- The Ronald O Perelman Department of Dermatology, New York University Langone Health, New York, New York, USA.
ORCID-Profile: Jordan V Wang, Roy G Geronemus
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Hashemi, D. A., Tao, J., Wang, J. V., & Geronemus, R. G. (2025). The 595‐nm Wavelength Pulsed Dye Laser for Pediatric Port‐Wine Birthmarks and Infantile Hemangiomas: A Systematic Review. Lasers in Surgery and Medicine, 57(1), 27-36. https://doi.org/10.1002/lsm.23864
Vancouver
Hashemi DA, Tao J, Wang JV, Geronemus RG. The 595‐nm Wavelength Pulsed Dye Laser for Pediatric Port‐Wine Birthmarks and Infantile Hemangiomas: A Systematic Review. Lasers in Surgery and Medicine. 2025;57(1):27-36. doi:10.1002/lsm.23864
BibTeX
@article{Hashemi2025,
author = {Hashemi, David A and Tao, Joy and Wang, Jordan V and Geronemus, Roy G},
title = {The 595‐nm Wavelength Pulsed Dye Laser for Pediatric Port‐Wine Birthmarks and Infantile Hemangiomas: A Systematic Review},
journal = {Lasers in Surgery and Medicine},
year = {2025},
volume = {57},
number = {1},
pages = {27--36},
doi = {10.1002/lsm.23864}
}
EUVIMED